Nanox Receives FDA Clearance for HealthFLD, an Advanced AI-Based Software Empowering Clinicians in Assessment of Fatty Liver

Go back to Nanox Receives FDA Clearance for HealthFLD, an Advanced AI-Based Software Empowering Clinicians in Assessment of Fatty Liver
(NASDAQ: NNOX) Delayed: 0.73 -0.05 (6.41%)
Previous Close $0.78    52 Week High
Open $0.80    52 Week Low
Day High $0.81    P/E N/A 
Day Low $0.73    EPS
Volume 874,228